Ellen M. Beasley Ph.D. — Senior Vice President of Products & Services R&D at Genomic Health

Dr. Ellen M. Beasley, Ph.D., serves as Senior Vice President of Products and Services Research & Development at Genomic Health Inc. Since joining Genomic Health in 2013, Dr. Beasley has focused on the application of next generation technologies, including sequencing and liquid-based biopsy, to discover and develop Genomic Health's next generation of products to treat patients living with cancer. She served as Vice President of Project Management of Perlegen Sciences Inc., since October 2007. She also served as Senior Vice President of Research & Development Operations, managing companion diagnostic programs and building the CLIA lab for commercialization of a breast cancer risk assay. Prior to that, she held a number of leadership roles with Celera Group including Senior Director of Therapeutics Alliances, Senior Director of Bioinformatics and Director of Gene Discovery. Prior to Celera, she served as a Project Manager at the Stanford Human Genome Center. Dr. Beasley has over 20 years of product development and program management experience in biotechnology and genomics sciences. She has a record of successful integration and application of bioinformatics, genetics and genomics platforms to advance and accelerate life sciences instrument, diagnostics and therapeutics product discovery and development. She started her career in human genomics at the Stanford Human Genome Center and lead the team developing physical maps of the human genome. Dr. Beasley then moved to Celera Genomics and participated in the genome sequencing and gene discovery efforts for the human genome. After the completion of the human genome, she managed various discovery efforts to apply the human genome, including drug target discovery efforts, investigation of the genetic basis of autoimmune disease and companion diagnostic partnership development. In 2009, she joined Life Technologies and served as Vice President of Biological Information Systems, leading a team to develop methods and software tools to exploit the data from next generation sequencers. Dr. Beasley received a B.S. in Biology from Trinity College (Hartford, CT) and a Ph.D. in Molecular Genetics & Cell Biology from The University of Chicago, she completed Post-Doctoral Training at the Biozentrum of the University of Basel in Switzerland and Stanford University. She is an Inventor on approximately 170 patents.